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Many patients with hypertrophic cardiomyopathy have
signs and symptoms of myocardial ischemia and dys-
function. Although hypertrophy and increased left ven-
tricular pressure can account for such abnormalities,
altered small intramural coronary arteries have also been
described in such patients. To determine the prevalence
and extent as well as the clinical relevance of abnormal
intramural coronary arteries, a histologic analysis of left
ventricular myocardium obtained at necropsy was per-
formed in 48 patients with hypertrophic cardiomyopathy
(but without atherosclerosis of the extramural coronary
arteries) and in 68 control patients with either a normal
heart or acquired heart disease.
In hypertrophic cardiomyopathy, abnormal intra-
mural coronary arteries were characterized by thick-
ening of the vessel wall and a decrease in luminal size.
The wall thickening was due to proliferation of medial
or intimal components, or both, particularly smooth
muscle cells and collagen. Of the 48 patients with hy-
pertrophic cardiomyopathy, 40 (83%) had abnormalities
of intramural coronary arteries located in the ventric-
ular septum (33 patients), anterior left ventricular free
wall (20 patients) or posterior free wall (9 patients); an
average of 3.0 ± 0.7 abnormal arteries were identified
per tissue section. Altered intramural coronary arteries
were also significantly more common in tissue sections
having considerable myocardial fibrosis (31 [74%] of 42)
Hypertrophic cardiomyopathy is a cardiac disease with a
variety of clinical and morphologic features (I-II). Many
patients with hypertrophic cardiomyopathy manifest evi-
dence of myocardial ischemia or damage, including angina
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than in those with no or mild fibrosis (31 [30%] of 102;
p < 0.001). Abnormal intramural coronary arteries were
also identified in three of eight infants who died of hy-
pertrophic cardiomyopathy before I year of age.
In contrast, only rare altered intramural coronary
arteries were identified in 6 (9%) of the 68 control pa-
tients (0.1 ± 0.05 abnormal arteries per section; p <
0.001) and those arteries showed only mild thickening
of the wall and minimal luminal narrowing. Moreover,
of those patients with abnormal intramural coronary
arteries, such vesselswere about 20 times more frequent
in patients with hypertrophic cardiomyopathy (0.9 ±
0.2/cm2 myocardium) than in control patients (0.04 ±
0.02/cm2 myocardium).
Hence, abnormal intramural coronary arteries with
markedly thickened walls and narrowed lumens are
present in increased numbers in most patients with hy-
pertrophic cardiomyopathy studied at necropsy and may
represent a congenital component of the underlying car-
diomyopathic process. Although the clinical significance
of "small vessel coronary artery disease" in hyper-
trophic cardiomyopathy is unclear, the occurrence of
structurally altered intramural coronary arteries in areas
of substantial myocardial fibrosis suggests acausal role
for these arteries in producing ischemia.
(J Am Colt CardioI1986;8:545-57)
pectoris or atypical chest pain (4,6,12), certain electrocar-
diographic abnormalities (13-16), myocardial fibrosis (10, 17)
and abnormalities in coronary blood flow and lactate pro-
duction during stress (18,19). In this investigation, we con-
sidered the possibility that structural alterations in the in-
tramural coronary arteries (20-22) could contribute to
myocardial ischemia in patients with hypertrophic cardio-
myopathy. We examined histologic sections of ventricular
myocardium from 48 patients with hypertrophic cardio-
myopathy and from 68 patients with acquired cardiac disease
or a normal heart to determine the prevalence and severity
of abnormal intramural coronary arteries and their relation
to areas of fibrosis.
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*Hea rt we ight > 400 g. tlncludes I I patients with predominant or
pure aort ic stenosis as well as 2 with com~ined aorti c stenosis and regur-
gitation, I with associated coronary heart disease and I With an .assoclate.d
atrial septal defect. *Includes one pat ient with combined aornc ste~osls
and atrial septal defect and one patient with aortic stenosis and associated
coro nary heart disease. IMCAs = intramural coronary artenes.
Methods
Selection of patients. The cardiovascular registry of the
Pathology Branch of the National Heart , Lung , and Blood
Institute was reviewed and 154 hearts of children and adult s
with hypertrophic cardiomyopathy were identified and con-
sidered for inclu sion in the study . Of this number, 106 were
excluded for one or more of the following reasons: I) there
was associated cardiac disea se such as systemic hyperten-
sion, aortic valve stenosis , mitral valve prolapse or coronary
heart disease (>50% narrowing of the cross-sectional lumen
of one or more extramural [epicardial] coronary arteries)
(37 patients) or systemic disease including insulin-depen-
dent diabetes mellitus (7 patients); 2) the patient had had a
previous operation (ventricular septal myotomy-myectomy)
and had survived more than I month postoperatively (19
patients); 3) the specimen was in poor condition and tissue
suitable for histologic analysis could not be obtained from
the standard three sites in the septum and left ventricular
free wall described below (18 patients); or 4) the heart was
con sidered to be a particularly good example of hypertrophic
card iomyopathy that we wished to preserve intact (25 pa-
tients). The remaining 48 patients constitute the study group .
Each patient met our definition of hypertrophic cardio-
myopathy by virtue of having a hypertroph~ed , nondilat~d
left ventricle in the absence of another cardiac or systemic
disease that could produce left ventricular hypertrophy (23).
In addition to these 48 patients , 8 infants who died of hy-
pertrophic cardiomyopathy (24 ,25 ) (7 live-~o~n an~ 1 ~till ­
born) were examined separately as part of this mvestiganon .
Control patients . In addition, 68 patients without hy-
pertrophic cardiomyopathy were selected as controls, ~n­
eluding 14 without evidence of cardiac disease and 54 With
a variety of relatively common acquired cardiac diseases
characterized by an increase in left ventricular mass (Table
I) . Becau se our control group was defined in this fashion,
it did not include several congenital cardiac or systemic
diseases in which intramural coronary artery abnormalities
Table 1. Cardiac Disease in 68 Conlrol Patients
Disease
Coronary heart disease *
Aortic valvular disease
Systemic hypertension
Dilated cardiomyopathy
Normal
TOlal
No . of
Patient s
18
15t
13
8
14
68
No . With
Abnormal IMCA s
I
2t
I
o
2
6
had already been described (2 1,26, 27). Each of the 54 pa-
tients with card iac disease had clinically or hemodynami-
cally significant lesions and died suddenly, or of compli-
cations of surgery or cardiac catheterization, or of congestive
heart failure . Certain demographic, clinical and morpho-
logic data in patients with hypertrophic cardiomyopathy and
control patients are summarized in Tables 2 and 3.
Preparation of tissue. Each of the 124 heart s utilized
in this study (from 48 children or adult s with hypertrophic
cardiomyopath y, 8 infants with hypertrophic cardio-
myopathy and 68 control subjects) was fixed in formalin .
Tissue blocks were taken from the full thickness of the
ventricular wall in a plane perpendicular to the long axis of
the left ventricle (that is, a transverse plane), about half the
distance between the aortic valve and left ventricular apex .
Tissue sections were obtained from three locations: ven-
tricular septum, anterior left ventricular free wall (about 2
em lateral to the left anterior descending coronary artery)
and posterior left ventricular free wall (between the papilla~y
muscles) (Fig. 1) (28). Each tissue block was embedded III
paraffin, sectioned at 6 f-L and stained with Movat ' s pen-
tachrome stain (29).
Analysis of intramural coronary arteries. Asse ssment
of intramural coronary artery anatomy was confined to those
arterie s « I ,500 f-L in diameter) that were viewed in cross
section (transverse cut) without obvious obliquity and that
did not appear to be branches of another intramural vessel,
or portions of a " tunneled" epicardial vessel. Small coro-
nary arteries in trabeculae or papillary muscles were ex-
cluded from analysis .
The extent to which abnormal intramural coronary ar-
teries occurred in each tissue section was graded semi-
quantitatively based on the number of abnormal arteries and
on an estimation of the degree of wall thickening and luminal
narrowing. The grading system used to express the mag-
nitude of these abnormalities was as follows. First, the fre-
quency of altered arteries in a tissue section was assessed
and numeric values of 0.5 to 9.5 were assigned to reflect
the number of abnormal intramural coronary arteries iden-
tified . Sections with only a single altered intramural coro-
nary artery were not considered abnormal. Second , for each
intramural coronary artery judged to be abnormal the se-
verity of wall thickening and apparent luminal narrowing
was graded qualitatively as mild (I + ), moderate (2 + ) or
severe (3 +). Grades for frequency and severity were then
averaged to yield an overall assessment of abnormal intra-
mural coronary artery morphology for each section. These
values were then summed for all three tissue sections taken
from each patient, giving an overall "abnormal intramural
coronary artery tissue section grade."
Prior knowledge of whether or not tissue sections studied
were from patients with hypertrophic cardiomyopathy or
control patients was usually unavoidable because particu-
larly large tissue section size or the presence of marked
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cardiac muscle cell disorganization suggested the presence
of hypertrophic cardiomyopathy .
Analysis of myocardial fibrosis. The extent of fibrous
tissue formation was assessed qualitatively in each tissue
section: 0 (none) , 1+ (mild), 2 + (moderate) and 3 + (se-
vere) . Mild fibrosis was judged to be present when an iso-
lated small scar or interstitial fibrous tissue formation, or
both , was identified; severe fibrosis was characterized by
extensive replacement scarring occupy ing substantial por-
tions of the section . Moderate fibrosis consisted of degrees
of replacement scarring intermediate in extent between that
observed with the mild and severe grades . Transmural in-
farction was defined as involv ing at least the inner two-
thirds of the ventricular wall.
Measurement of tissue section area. The area of each
of the 348 tissue sections analyzed in this study was cal-
culated using a previously described method (30). The boun-
daries of each section (exclusive of trabeculae and papillary
muscles) were traced on ordinary tablet paper with a fine
point marking pen and the area was then measured (in square
centimeters) utilizing a video planimeter.
Clinical features. Of the 48 patients with hypertrophic
cardiomyopathy, 26 died suddenly and unexpectedly; 9 died
from progressive congesti ve heart failure, 10 died at op-
eration and 1 each died from cerebrovascular accident, com-
plication s of cardiac catheterization and suicide. Sixteen
patients (34%) had been asymptomatic or minimally symp-
tomatic ; the remaining 32 (66%) had experienced substantial
functional limitation , includin g 10 with moderate symptoms
(New York Heart Association functional class II) and 22
with marked symptoms (class III or IV). Nineteen (40%)
of the 48 patients had chest pain .
Of 33 patients having cardiac catheterization, 18 had a
subaortic gradient of 30 mm Hg or more under basal con-
ditions (40 to 160 mm Hg; average 88), and the remaining
15 patients had zero basal gradient or a small gradient of
15 mm Hg or less. Of the latter 15 patients, 10 had pro-
vocative maneuvers performed in the cardiac catheterization
laboratory (Valsalva maneuver, isoproterenol infusion or
amyl nitrite inhalation) , which induced a gradient of 20 mm
Hg or less in 8 patients and 50 mm Hg or more in the other
2. Five other patients with no or a small gradient at rest did
not have provocative maneuvers performed.
The eight infants with hypertrophic cardiomyopathy ranged
in age at the time of death from stillborn to II months (mean
4 months ); six were male and two were female. Of the seven
live-born infants , four died of progressive congesti ve heart
failure, one died suddenly and two died postoperati vely.
Interobserver variation. To assess interobserver vari-
ability in the identification of abnormal intramural coronary
arteries, 36 tissue sections (12 each of ventricular septum,
anterior and posterior free wall) from 12 study patients (10
with hypertrophic cardiomyopathy and 2 with other cardiac
diseases) were analyzed independently by two observers.
Each investigator determined whether or not individual tis-
sue sections showed two or more abnormal arteries .
Statistical methods. Data were expressed as the
mean ± SEM . Differences between means were assessed
with the Student's t test. Differences between proportions
were evaluated with the chi-square test.
Results
Histologic features of abnormal intramural coronary
arteries. Compared with normal intramural coronary ar-
teries (Fig . 2), abnormal arteries were characterized by in-
creased size and thickened walls (Fig. 3 to 6); usually the
lumen was narrowed, although some of these arteries had
a normal-sized or apparently dilated lumen. Thickening of
the arterial wall was due to proliferation of medial or intimal
components, particularly smooth muscle cells and collagen .
Also , increased numbers of elastic fibers were often present
in the intima , and mucoid deposits (acid mucopolysaccha-
ride) were occasionally identified in the intima or media .
In some arteries isolated intimal proliferation was localized
to only a portion of the luminal circumference. The internal
elastic membrane was frequently distorted or obscured ,
making it difficult or impossible to discern the relative con-
tribution of the intima or media to thickening of the arterial
wall.
Control patients. Of the 68 control patients with a nor-
mal heart or cardiac disease other than hypertrophic car-
diomyopathy , 6 (9%) had abnormal intramural coronary
arteries present in at least one tissue section , including ven-
tricular septum (5 patients ) or posterior free wall (1 patient)
(Fig. 7 and 8). Therefore, abnormal arteries were present
in only 6 (3%) ofthe 204 individual tissue sections analyzed,
and were most common in the ventricular septum. The re-
maining 62 (91%) patients did not show altered intramural
arteries in any of the tissue sections examined.
A total of 15 abnormal intramural coronary arteries were
identified in the 204 sections, an average of 0.1 ± 0.05/section
and 0 .04 ± 0 .02/cm2 of myocardium analyzed (Table 4) .
The maximal number of abnormal arterie s present in any
single section was three .
Altered intramural coronary arteries ranged in external
diameter from 90 to 390 f..t (mean 215) . Most abnormal
arteries (13 [87%] of 15) were midly or moderately narrowed
with localized or modest intimal or medial thickening; only
2 (13%) of 15 were considered to be markedly thickened
and appeared narrowed . The overall abnormal intramural
coronary artery tissue section grade , reflecting the frequenc y
and severity of arterial abnormalities for combined ven-
tricular septum and free wall, was 0.08 ± 0.03 (Fig. 9;
Table 4).
Patients with hypertrophic cardiomyopathy. Of the
48 patients with hypertrophic cardiomyopathy, 40 (83%)
had abnormal intramural coronary arteries in at least one
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Table 2. Clinical and Morphologic Data in 48 Patients With Hypertrophic Cardiomyopathy
LVOT PSG
Age (yr) Mode of (mm Hg) HW VS PW
Case &Sex Death CP FC Rest Prov o (g) (mm) (rnrn) VS/PW
I IIF SO 0 1 400 17 9 1.9
2 12M SO 0 I 270 18 10 1.8
3 13M CHF 0 3 15 50 520 23 17 1.3
4 13M SO 0 I 450 21 14 1.5
5 14M SO 0 I 15 360 18 12 1.5
6 15F SO 0 I 55 115 400 38 16 2.6
7 15F SO 0 1 320 22 II 2.0
8 15M SO 0 1 650 35 18 1.9
9 17M SO 0 I 370 27 13 2. 1
10 17M SO 0 1 530 21 12 1.8
I I 19F SO + 2 40 320 24 15 1.6
12 19F Op + 3 160 730 28 25 I I
13 20F CHF + 2 40 55 1,250 42 10 4 .2
14 20M SO 0 1 630 33 20 1.7
15 21F Op + 3 80 100 390 29 15 1.9
16 21F SO 0 1 400 24 9 2.7
17 22M SO 0 I 500 21 13 1.6
18 23M SO 0 I 0 500 20 15 1.3
19 23M SO 0 I 750 30 15 2.0
20 24F SO 0 2 720 44 26 1.7
21 24F CVA 0 2 0 385 24 II 2.2
22 25F Op + 3 0 0 400 25 15 1.7
23 26F SO + 2 65 500 23 14 1.6
24 26F CHF 0 3 10 390 22 16 1.4
25 27F SO + 3 100 640 33 20 1.6
26 27M Op + 3 70 950 34 27 1.3
27 27F Cath + 2 130 490 30 19 1.6
28 28F Op + 3 80 580 28 17 1.6
29 29M SO 0 4# 0 0 450 25 12 2.1
30 30F SO 0 I 445 17 15 1.1
31 30F CHF + 2 0 20 525 17 21 0 .8
32 33M SO + 2 0 15 1,020 34 25 1.4
33 33F CHF + 4 0 10 430 27 13 2.1
34 33M CHF + 3 0 0 580 15 15 1.0
35 33F SO 0 2 120 550 35 19 1.8
36 35F SO + 3 100 620 36 25 1.4
37 37M Op + 3 65 160 680 27 18 1.5
38 38M SO + 3 0 0 560 25 15 1.7
39 38M SO 0 2 85 130 600 26 21 1.2
40 41F Op 0 4 0 530 25 16 1.6
41 41M Op 0 3 15 100 700 27 17 1.6
42 43F SO 0 1 300 18 II 1.6
43 43F CHF 0 4 55 75 310 18 16 1.1
44 50F Su + 3 130 450 20 19 1.1
45 50F CHF 0 3 0 5 550 15 10 1.5
46 53M Op 0 3 110 140 800 32 18 1.8
47 59F Op + 3 100 610 23 23 1.0
48 60M CHF 0 4 530 16 12 1.3
*Denotes number of abnormal intramural coronary arteries per tissue section. t Qualitative assessment (1 + to 3 + ) of the degree of wa ll thickening
and luminal narrowing in all abnormal intramural coronary arteries in the tissue section (with I + the most mild and 3 + the most severe) . t Mean external
diameter of all abnormal intram ural coronary arteries in the tissue section. §Qualitative assessment (I + to 3 +) of the degree and extent of fibrosis
observed in the tissue section; mild (I +) fibrosis was judged to be present when an isolated small scar or inte rstitial fibrous tissue forma tion. or both .
was identified; severe (3 +) fibrosis was characterized by extensive replacement scarring occupying substantial port ions of the section; moderate (2 + )
fibrosis consisted of degrees of replacement scarring intermediate in extent between that observed with the mild or severe grades . II"Tissue section grade "
(TSG) is a numeric expression of the frequency and severity of abnormal intramural coronary arteries in combined ventricular septal and free wall tissue
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Table 2. (continued)
Abnormal Intramural Coronary Arteries
Ventricular Septum Anterior LVFW Posterior LVFW
Overall
No.* st(O to 3+) Dt(/L) Fi§ No.* st(O to 3+) Dt(/L) F§ No* st(O to 3+) Dt(/L) Fi§ TSGII
2 2+ 315 1+ 2 2+ 355 1+ 0 0 0 0 2.35
12 2+ 370 2+ 4 1+ 215 1+ 0 0 0 1+ 3.35
4 2+ 335 3+ 0 0 0 1+ 0 0 0 0 lAO
2 2+ 700 1+ 0 0 0 0 0 0 0 0 1.30
4 2+ 410 2+ 0 0 0 1+ 0 0 0 0 1.30
0 0 240 1+ 3 3+ 355 1+ 0 0 0 1+ 1.60
0 0 0 1+ 0 0 0 0 0 0 0 0 0
7 1+ 300 3+ 4 3+ 580 2+ 0 0 0 1+ 3.35
5 2+ 350 2+ 2 1+ 150 1+ 0 0 0 1+ 2.25
0 0 0 1+ 0 0 0 1+ 0 0 0 0 0
2 1+ 305 1+ 0 0 0 0 2 1+ 185 1+ 1.60
2 3+ 370 1+ 2 1+ 270 1+ 0 0 0 2+ 2.15
5 1+ 155 3+ ** 3 1+ 175 3+ 6 1+ 225 3+ 3.75
15 2+ 455 1+ 0 0 0 0 0 0 0 1+ 2.75
0 0 0 1+ 0 0 0 1+ 0 0 0 0 0
10 2+ 395 2+ 2 2+ 400 1+ 2 1+ 140 1+ 4.10
0 0 0 1+ 0 0 0 1+ 2 2+ 240 0 1.30
0 0 0 0 0 0 0 0 2 1+ 295 0 0.80
0 0 0 1+ 0 0 0 1+ 0 0 0 2+ 0
0 0 0 1+ 2 2+ 205 1+ 0 0 0 1+ 1.05
18 2+ 250 3+ 3 2+ 205 2+ 4 2+ 360 2+ 5.90
6 2+ 360 2+ 5 2+ 205 2+ 3 1+ 225 1+ 4.25
4 1+ 290 1+ 0 0 0 0 0 0 0 0 1.05
2 1+ 305 2+ 0 0 0 0 0 0 0 1+ 0.80
50 3+ 290 3+** 0 0 0 2+ 0 0 0 1+ 6.50
3 2+ 295 0 4 2+ 195 3+ 0 0 0 2+ 2.70
0 0 0 1+ 0 0 0 2+ 0 0 0 1+ 0
0 0 0 2+ 0 0 0 1+ 0 0 0 0 0
3 1+ 205 1+ 0 0 0 0 0 0 0 0 0.95
0 0 0 0 5 1+ 200 1+ 0 0 0 0 lAO
4 2+ 230 3+** 2 2+ 230 3+ 0 0 0 1+ 1.75
3 2+ 355 2+ 2 2+ 475 3+ 0 0 0 1+ 2.50
16 2+ 360 3+ 0 0 0 3+ 0 0 0 1+ 2.00
76 3+ 345 3+ ** 0 0 0 2+ 0 0 0 1+ 9.25
0 0 0 2+ 0 0 0 1+ 0 0 0 1+ 0
4 2+ 295 1+ 0 0 0 1+ 0 0 0 1+ 1.30
0 0 0 0 8 1+ 100 0 0 0 0 1+ 1.50
4 2+ 145 1+ 7 2+ 160 3 + ** 0 0 0 1+ 3.10
7 1+ 255 1+ 0 0 0 1+ 0 0 0 1+ 1.55
7 2+ 215 3+ ** 0 0 0 2+ 0 0 0 1+ 1.76
0 0 0 0 3 2+ 360 0 0 0 0 1+ 1.30
8 2+ 325 1+ 0 0 0 1+ 0 0 0 0 1.95
3 1+ 315 2+ 3 1+ 270 2+ 0 0 0 1+ 2.05
3 2+ 190 1+ 0 0 0 0 0 0 0 1+ 1.30
22 2+ 370 3+** 0 0 0 2+ 5 2+ 355 2+ 4.90
4 1+ 360 1+ 7 1+ 180 0 2 1+ 180 0 3.55
0 0 0 0 0 0 0 0 0 0 0 1+ 0
15 2+ 245 3+** 0 0 0 1+ 0 0 0 1+ 2.80
sections for each patient (see text for details). #Assigned to functional class IV by virtue of experiencing and surviving an episode of cardiovascular
collapse (associated with documented ventricular fibrillation) 8 months before his sudden death. **Replacement fibrosis is transmural. Cath = cardiac
catheterization; CHF = congestive heart failure; CP = chest pain; CVA = cerebrovascular accident; D = (external) diameter; F = female; FC =
functional class; Fi = fibrosis; HW = heart weight; IMCA = intramural coronary artery; LVFW = left ventricular free wall; LVOT = left ventricular
outflow tract; M = male; Op = operation; Prov. = provokable; PSG = peak systolic gradient; PW = posterior left ventricular free wall thickness;
S = severity; SD = sudden death; Su = suicide; TSG = tissue section grade; VS = ventricular septal thickness; + = present; 0 = absent.
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Table 3. Demographic, Clinical and Morphologic Data in 48 Patients with Hypertrophic Cardiomyopathy and 68 Control Patients*
Age at
No. Death Sex vst pwt No. (%) With Heart weight
Patients (yr) (% male) (mm) (mm) VS/PW Abnormal IMCAs (g)
Hypertrophic cardiomyopathy 48t 29 44 26 16 1.7 40/48 542
(II to 60) (15 to 44) (91026) (0.8 to 4.2) (83%) (270 to 1,250)
Controls 68 48 69 16 15 1.1 6/68 526
(13 to 80) (10 to 34) (9 to 23) (0.8 to 2.0) (9%) (250 to 900)
p Value <0.001 <0.001 NS <0.001 <0.001 NS
*Data presented as mean and range, where applicable. tVentricular septal measurements were made at the point of maximal thickness. usually about
half the distance between the aortic valve and left ventricular apex. Left ventricular posterior wall measurements were taken behind the midpoint of the
posterior mitral leaflet, at a level corresponding to the tips of the mitral leaflets; trabeculae. papillary muscles and crista supraventricularis muscle were.
by convention, excluded from these measurements. tDoes not include eight infants with hypertrophic cardiomyopathy who were analyzed separately;
ventricular septal thicknesses were 8 to 30 mm (mean 16), posterior free wall thicknesses were 3 to 15 mm (mean 9) and septal-free wall ratios were
1.4 to 2.7 (mean 1.9). IMCAs = intramural coronary arteries; NS = nonsignificant; PW = posterior left ventricular free wall; VS = ventricular septum;
VS/PW = ventricular septal to free wall thickness ratio.
tissue section; hence, the prevalence of abnormal sections
was significantly greater in the patients with hypertrophic
cardiomyopathy than in control patients (83 versus 9%;
p < 0.001) (Fig. 7). In patients with hypertrophic cardio-
myopathy, altered intramural coronary arteries were iden-
tified in the ventricular septum (33 patients), anterior free
wall (20 patients) or posterior free wall (9 patients) (Table
2; Fig. 8). Therefore, abnormal arteries were present in 62
(43%) of the 144 individual tissue sections analyzed and
most commonly appeared in ventricular septum. Of the 40
patients with abnormal intramural coronary arteries, such
vessels were identified in one of the three tissue sections in
23 patients, in two sections in 12 patients and in all three
sections in only 5 patients.
A total of 433 abnormal intramural coronary arteries
were identified in the /44 tissue sections, an average of 3.0
± O.7/section and 0.9 ± 0.2/cm2 of myocardium analyzed;
their frequency was significantly greater in patients with
hypertrophic cardiomyopathy than in control patients, (p <
0.001) (Table 4). The maximal number of altered arteries
present in any single section was 76.
Occasionally, numerous abnormal intramural coronary
Figure 1. Section of left ventricle (LV) in the anteroposterior
(transverse) plane about half the distance between base and apex,
showing the location of the three tissue sections that were analyzed
quantitatively in each study patient. LVFW = left ventricular free
wall; RV = right ventricle.
ANTERIOR
LVFW
arteries appeared in clusters, but the distribution of ab-
normal arteries throughout the tissue section showed no
particular predilection for the subendocardial or subepicar-
dial regions. There was no significant relation between the
frequency of abnormal arteries and thickness of either ven-
tricular septum (r = 0.18) or posteriorfree wall (r = 0.43).
Abnormal intramural coronary arteries in patients with
hypertrophic cardiomyopathy were also larger (range 50 to
1,330 p, in external diameter; mean 300) (Table 2) than
those in controls (90 to 390 u; mean 215). Most altered
arteries (288 [64%] of 452) were markedly thickened and
usually narrowed, whereas the remainder (164 or 36%) were
judged only mildly or moderately narrowed with mild or
localized intimal or medial thickening.
The overall" abnormal intramural coronary artery tissue
section grade" (for septum and free wall combined) was
substantially greater in patients with hypertrophic cardio-
Figure 2. Normal intramural coronary artery in the ventricular
septum. The internal elastic membrane (lEM) is well visualized
adjacent to the sizeable lumen. Original magnification x 220, re-
duced by 26%.
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Figure3. Portion of ventricular sep-
tum from a patient with hypertrophic
cardiomyopathy. Numerous abnor-
mal intramural coronary arteries are
present; most are larger than normal
and have a thicker wall than normal
and a small lumen. This patient is
not included in the present study group
because she died more than I month
after the septal myotomy-m yectomy
operation. Original magnification
x 5, reduced by 26%. LV == left
ventricular cavity.
Figure4. a , A single large abnormal
intramural coronary artery is seen in
an interstitial space of the left ven-
tricular free wall . Original magnifi-
cation x 100. b, The same vessel at
higher magnification ( x 350). The
wall thickening is due primarily to
proliferation of medial (M) compo-
nents , although the intima (I) is also
mildly thickened . The internal elas-
tic membrane (!EM) is well defined .
Both panels reduced by 26%.
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Figure 5. Four photomicrographs (a to
d) showing substantial replacement
scarring of the ventricular septum and
abnormal intramural coronary arteries.
a, Low power view showing transmural
scarring of the septum and numerous
altered intramural coronary arteries; some
intramural coronary arteries have a
thickened wall and narrowed lumen.
Original magnification x 8. b, Higher
power view of the septum shown in a;
the two intramural coronary arteries
within the boxare indicated in a similar
fashion ina. Original magnification x 20.
c, High power micrograph of an abnor-
mal intramural coronary artery sur-
rounded by fibrous tissue that is desig-
nated by the arrow in a; luminal
narrowing is due primarily to prolifer-
ation of intimal smooth muscle; the small
medial (M) layer is evident at the pe-
riphery. Original magnification x 100.
d, Abnormal intramural coronary artery
in which luminal narrowing is due pri-
marily to medial fibrous tissue prolif-
eration. Original magnification x 100.
All reduced by 26%.
Figure 6. a, A portion of ventricular sep-
tum with only small patchy areas of fibro-
sis. Abnormal intramural coronary arteries
are present in or near both scarred and non-
scarred areas. Original magnification x 20.
b, Area of left ventricular free wall in which
numerous abnormal intramural coronary ar-
teries are present in a region of scarring,
as well as in an adjacent area of myocar-
dium that is not scarred. Original magni-
fication x 55. Both reduced by 26%.
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Figure 7. Prevalence of abnormal intramural coronary arteries
(IMCAs) in patients with hypertrophic cardiomyopathy (HCM)
and control subjects, and in tissue sections from these two groups
of patients.
40
_ HCM
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Figure 8. Distribution of abnormal intramural coronary arteries
(IMCAs) in the left ventricle (LV) of patients with hypertrophic
cardiomyopathy (HCM) and control subjects. ANT. FW = an-
terior free wall; POST. FW = posterior free wall; VS = ven-
tricular septum.
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Transmural scarring was present in tissue sections from
eight patients, including ventricular septum in seven and
anterior free wall in one. In each of these sections, clusters
of large numbers of abnormal intramural coronary arteries
were present either within or adjacent to the scar (Fig. 5
and 6). Most of these arteries had a small, narrowed lumen,
although in occasional vessels the arterial lumen appeared
normal or even dilated. The relation between abnormal in-
tramural arteries and myocardial fibrosis was not influenced
by the age or sex of the patient. Of the six tissue sections
with abnormal intramural coronary arteries in the control
group, only one showed moderate fibrosis, while the re-
mainder had either no or mild fibrosis.
Correlation of abnormal intramural coronary arter-
ies with other clinical or morphologic findings. Various
clinical, hemodynamic and morphologic findings in the 48
patients with hypertrophic cardiomyopathy were correlated
with the prevalence and severity of abnormal intramural
coronary arteries. There was no correlation between the
occurrence or magnitude of intramural coronary artery ab-
normalities and age of the patient, sex distribution, presence
or absence or severity of symptoms, mode of death (sudden
versus chronic decompensation), left ventricular end-dia-
stolic pressure, heart weight, ventricular septal thickness or
septal to free wall thickness ratio. Although there was no
statistically significant relation between the presence, ab-
sence or magnitude of left ventricular outflow obstruction
and small artery abnormalities (in the 32 patients who under-
went cardiac catheterization), the abnormal intramural coro-
nary artery tissue section grade in patients with nonobstruc-
tive hypertrophic cardiomyopathy (2.8 ± 0.6) tended to
exceed that of patients with obstructive hypertrophic car-
diomyopathy (1.6 ± 0.4; p < 0.2). Altered arteries were
present in each of the 15 patients with nonobstructive hy-
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myopathy (2.1 ± 0.1) than in control patients (0.08 ±
0.03; p < 0.001) (Fig. 9; Table 3). Furthermore, in patients
with hypertrophic cardiomyopathy, the magnitude of intra-
mural coronary artery abnormalities was significantly greater
in the ventricular septum than in the anterior free wall and
greater in the anterior free wall than in the posterior free
wall (Fig. 9).
Abnormal intramural coronary arteries were identified
in the ventricular septum from three ofthe eight infants with
hypertrophic cardiomyopathy. In two of these three infants
numerous altered arteries had moderate to marked thick-
ening of the vessel wall and luminal narrowing; in the re-
maining infant, milder arterial abnormalities were identified.
Fibrosis was not associated with the abnormal arteries in
the three infants.
Relation between abnormal intramural coronary ar-
teries and myocardial fibrosis. In the 48 patients with
hypertrophic cardiomyopathy, myocardial scarring was ab-
sent or mild in 102 tissue sections and moderate to severe
in 42 sections. Abnormal intramural coronary arteries were
significantly more common in those tissue sections with
moderate or severe fibrosis (31 [74%] of 42) than in sections
with no or mild fibrosis (31 [30%] of 102; P < 0.001) (Fig.
10). The association between altered intramural arteries and
fibrosis was most significant in ventricular septal sections;
abnormal arteries were present in 19 (90%) of 21 septal
sections with moderate to marked fibrosis, but in only 14
(52%) of 27 septal sections with no or mild fibrosis (p <
0.025). In 24 of the 31 sections in which abnormal intra-
mural coronary arteries and substantial fibrosis were present,
a particularly close association between the two was ap-
parent, with abnormal arteries located either within or at
the margins of areas of replacement fibrosis (Fig. 5 and 6).
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Table 4. Frequency of Abnormal Intramural Coronary Arteries in Patients With Hypertrophic
Cardiomyopathy and Control Subjects
Hypertrophic
Cardiomyopathy Control Group
No. of patients
Total no. of abnormal IMCAs
Avg. no. of abnormal 1MCAs/tissue section
Maximal no. of abnormal 1MCAs/tissue section
Avg. tissue section area (cm2)t
Avg. no. of abnormal IMCAs/cm 2 of myocardium]
IMCA tissue section gradej
48
433
3.0 ± 0.7*
76
3.5 ± 0.2*
0.9 ± 0.2*
2.1 ± 0.1*
68
IS
0.1 ± 0.05*
3
2.3 ± 0.1*
0.04 ± 0.02*
0.08 ± 0.03*
*Comparison of these variables in patients with hypertrophic cardiomyopathy and control patients achieved
statistical significance, p < 0.001. tExpressed here for ventricular septum. anterior free wall and posterior free
wall combined. tAnalysis of only those tissue sections with abnormal intramural coronary arteries. §Reflects
the frequency as well as the severity of abnormal intramural coronary arteries; data presented here combine
ventricular septal and both free wall tissue sections in each patient (see text for details). Avg. = average;
IMCAs = intramural coronary arteries.
pertrophic cardiomyopathy and in 12 of 17 patients with
obstructive hypertrophic cardiomyopathy.
Of the 48 patients with hypertrophic cardiomyopathy, 19
had experienced clinically significant and recurrent episodes
of chest pain. Of these 19 patients, 15 (79%) had abnormal
intramural coronary arteries in at least one tissue section;
however, these altered arteries were also commonly iden-
tified in patients without chest pain (25 [86%] of 29). Fur-
thermore, there was no relation between the occurrence of
chest pain and the extent of myocardial fibrosis; chest pain
was present in 12 (63%) of 19 patients with moderate to
marked fibrosis and in 14 (48%) of 29 patients with no or
mild fibrosis.
Interobserver variation. There was agreement between
two observers with regard to the presence or absence of
abnormal intramural arteries in 88% of observations (32 of
36 tissue sections analyzed).
Discussion
Occurrence and pathogenesis of abnormal intramural
coronary arteries in hypertrophic cardiomyopathy. The
findings of this study demonstrate that many patients (over
80%) with hypertrophic cardiomyopathy have structural ab-
normalities of the intramural coronary arteries. There was
great variation in the magnitude of these abnormalities, which
were striking in some patients and relatively mild in others.
Altered intramural coronary arteries were most common in
the ventricular septum, but were also frequently identified
in the anterior or posterior left ventricular free wall. These
Figure 9. Semiquantitative expression of magnitude of intramural
coronary artery (IMCAs) abnormalities in the 48 patients with
hypertrophic cardiomyopathy (HCM) and 68 control patients. Tis-
sue section grade utilized here takes into account both the frequency
of abnormal intramural coronary arteries and the apparent severity
of wall thickening and luminal narrowing (see text for details).
Figure 10. Relation between occurrence of abnormal intramural
coronary arteries (IMCAs) and myocardial fibrosis in 144 tissue
sections obtained from the ventricular septum and anterior and
posterior left ventricular free walls in 48 patients with hypertrophic
cardiomyopathy. Marked fibrosis includes those tissue sections
graded as moderate or severe.
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findings of abnormal intramural coronary arteries in hyper-
trophic cardiomyopathy are similar to those described in
several patients by James and Marshall (22). The present
study extends their observations, however, because our re-
sults allow a quantitative assessment of the prevalence, dis-
tribution and severity of these abnormal intramural coronary
arteries in patients who died of hypertrophic cardio-
myopathy, as well as in control patients with a variety of
other cardiac diseases.
Our findings indicate that the presence of abnormal in-
tramural coronary arteries is not unique for hypertrophic
cardiomyopathy; such vessels were also present in a few
control patients with a variety of cardiac diseases charac-
terized by left ventricular hypertrophy. However, the altered
intramural coronary arteries identified in our control patients
were much less frequent and less severe than those observed
in patients with hypertrophic cardiomyopathy. In particular,
their prevalence was much lower in patients with systemic
hypertension and in patients with valvular aortic stenosis.
Because these latter diseases lead to a pressure load on the
left ventricular myocardium, this finding indicates that myo-
cardial wall stress alone is not sufficient to produce these
abnormal intramural arteries in the frequency with which
they are found in hypertrophic cardiomyopathy. In addition,
our observations that intramural coronary artery abnormal-
ities were equally severe in patients with and without left
ventricular outflow obstruction and the lack of relation be-
tween left ventricular wall thickness and frequency or lo-
cation of abnormal intramural coronary arteries, further sub-
stantiate the conclusion that these abnormal arteries are not
solely related to elevated intramyocardial wall tension. Al-
though we have no definitive data that define the pathogen-
esis of the abnormal intramural coronary arteries present in
most patients with hypertrophic cardiomyopathy, the fact
that these altered arteries cannot be ascribed to high ven-
tricular pressures suggests that they may constitute an in-
dependent marker of hypertrophic cardiomyopathy and a
component of the cardiomyopathic process, which may be
present at birth (three of the eight infants with hypertrophic
cardiomyopathy we studied had abnormal intramural coro-
nary arteries). On the other hand, it is possible that in some
patients these abnormal intramural arteries arise secondary
to substantial or transmural fibrous tissue formation, as a
form of neovascularization.
Abnormal intramural coronary arteries in other dis-
eases. Previous investigators (26,27,31-37) have reported
alterations in small left ventricular intramural coronary ar-
teries (as well as in small arteries in the sinoatrial and atrio-
ventricular nodes) similar to those described in this report.
These observations, made primarily in patients with diseases
other than hypertrophic cardiomyopathy, included systemic
or metabolic diseases in which hypertrophy was absent or
mild, such as diabetes mellitus (26), progressive muscular
dystrophy (27), Friedreich's ataxia (27,31), scleroderma (32),
homocystinuria (33) and the Marfan syndrome (27). Ab-
normal intramural coronary arteries have also been de-
scribed in a diverse group of primary cardiovascular diseases
with or without left ventricular hypertrophy such as tunnel
subaortic stenosis (34), primary pulmonary hypertension
(27), Newfoundland dogs (35,36) with discrete fibrous sub-
aortic stenosis, newborns with aortic or pulmonic atresia
(37) and the syndrome of congenital deafness, syncope and
sudden death associated with QT interval prolongation (27).
In addition, small arteries with similar morphologic features
have been observed to be limited to the specialized sinoatrial
or atrioventricular conduction tissue of apparently healthy
young individuals (including competitive athletes) who died
suddenly and either had left ventricular hypertrophy (38) or
had no gross evidence of structural heart disease (39,40).
Although none of these studies attempted to quantitate the
frequency and severity of altered intramural coronary ar-
teries, it is our impression (based on a review of the pub-
lished papers) that these arteries occurred in relatively small
numbers, and therefore did not constitute the widespread
and potentially significant lesion that we observed in most
patients with hypertrophic cardiomyopathy.
Considerations regarding control subjects. The con-
trol group assembled for this study was comprised of patients
with a normal heart, dilated cardiomyopathy and acquired
heart disease associated with increased left ventricular pres-
sure, mass, or both (for example, systemic hypertension,
aortic valve disease and coronary heart disease). Therefore,
this particular control group was designed to reflect a pop-
ulation of adult patients with heart diseases that are relatively
common in cardiologic practice. As a result, many of the
congenital cardiac or systemic diseases in which abnormal
intramural coronary arteries have occasionally been reported
(as described earlier) are not represented. However, it was
not our intention in this investigation to suggest that ab-
normal intramural coronary arteries are more common in
hypertrophic cardiomyopathy than in any other cardiac or
systemic disease. Our study design permits only an assess-
ment of the relative frequency of these altered arteries in
hypertrophic cardiomyopathy as compared with other com-
mon cardiac diseases associated with left ventricular hy-
pertrophy.
Relation between abnormal intramural coronary ar-
teries and myocardial fibrosis. In our study there was no
clear relation between the presence of abnormal intramural
coronary arteries and the clinical history of chest pain in
patients with hypertrophic cardiomyopathy. Whereas about
80% of patients who had chest pain had altered intramural
coronary arteries, about 85% of patients who had no chest
pain also showed abnormal intramural coronary arteries. It
is conceivable that this lack of specificity of abnormal in-
tramural arteries for patients with chest pain may be due in
part to the fact that clinical assessment of chest pain in a
retrospective analysis such as ours is a difficult and subjec-
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tive judgment. Inaddition, "silent" ischemia has now been
well documented in patients with coronary artery disease
(41), and there is no reason to assume that this phenomenon
would be less common in hypertrophic cardiomyopathy.
Most importantly, however, our study identified an impor-
tant association between abnormal intramural coronary ar-
teries and objectively determined evidence of severe pro-
longed ischemia, that is, myocardial fibrosis. Altered
intramural coronary arteries were more commonly present
near or within areas of substantial fibrosis, and clusters of
increased numbers of these arteries were often identified in
transmural scars. In our view, this finding suggests that the
intramural coronary artery abnormalities identified in hy-
pertrophic cardiomyopathy are of pathophysiologic signif-
icance. We hypothesize that abnormal narrowed small ar-
teries compromise coronary blood flow, resulting in
myocardial ischemia which, if prolonged and severe, produces
myocardial necrosis and fibrous tissue formation.
Conclusions. The "small vessel" intramural coronary
artery disease identified in this study (in patients with and
without left ventricular outflow obstruction) constitutes a
common morphologic component of the disease process in
patients with hypertrophic cardiomyopathy. The presence
of abnormal intramural coronary arteries in some infants
who died of hypertrophic cardiomyopathy implies that these
abnormal arteries may be present from birth as part of the
developmental abnormality in hypertrophic cardio-
myopathy. The association of altered intramural arteries
with myocardial fibrosis suggests that these vessels may
contribute to the formation of myocardial fibrosis.
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